International Assessment of Remuneration Models for Hospital and Community Pharmacy
The International Pharmaceutical Federation (FIP) together with the World Health Organization has worked over many years to set standards for pharmaceutical services including human resources around the world. This includes work on analyzing financing and remuneration schemes of pharmaceutical services.
A large report by FIP published in 2009 found that there is no common terminology with respect to pharmaceutical services, payments and quality assurance, and this hampers any comparison of pharmaceutical remuneration models between countries and payment systems. It was also found that remuneration models vary widely, from the most basic ones that provide a fixed fee on the items dispensed, to a very complex model where different pharmaceutical services are charged. Apart from the 2009 FIP report, other multinational studies found substantial differences in the activities developed by pharmacy and their pharmaceutical remuneration models, which is another reason why comparison between countries is difficult.
Reforming remuneration models is urgent in many settings, as pharmaceutical and health expenditures increase with little evidence that they are adding value to existing health gains. The landmark report by FIP concluded that pharmacists not only need to demonstrate the value of their services, but to also ensure their quality.
Based on the findings of the 2009 report, FIP has recently established a working group to technically support the organization in carrying out a survey of all FIP member organizations, and has tasked the CGHD to design a member organization survey to assess remuneration models for hospital and community pharmacy, analyze the results, and write a report and publication.
|Principal Investigator||Veronika Wirtz|
|Boston University Co-Investigators||Warren Kaplan, Paul Ashigbie|
|Dates of Research||2013-2015|
|Donor/Funder||International Pharmaceutical Federation|